Sionna Therapeutics, Inc.
USD47.21
+1.52 (+3.33%)
CEO
Michael Cloonan
IPO Date
2025-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$46.45
Prev. Close
$45.69
Day Low
$45.24
Day High
$48.00
52W Low
$16.38
52W High
$51.56
Market Cap
$2.13B
Volume
0.57M
| 85,918 |
| $44.86 |
| 7 Jul 2026 | Fitzpatrick Jennifer | Chief Legal Officer | M-Exempt | Acquired | 10,250 | $6.11 |
| 7 Jul 2026 | Fitzpatrick Jennifer | Chief Legal Officer | S-Sale | Disposed | 10,250 | $43.60 |
| 7 Jul 2026 | Fitzpatrick Jennifer | Chief Legal Officer | M-Exempt | Disposed | 10,250 | $6.11 |
| 2 Jul 2026 | Thompson Peter A. | director | S-Sale | Disposed | 115,844 | $45.50 |
| 2 Jul 2026 | ORBIMED ADVISORS LLC | director | S-Sale | Disposed | 115,844 | $45.50 |
| 18 Jun 2026 | Stelzer Laurie | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Viney Joanne L. | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Thompson Peter A. | director | A-Award | Acquired | 17,340 | $36.73 |